Skip to content

Clinical trials

HIV Infections trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Not applicable Status: Unknown status Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20041
20054
20061
20072
20085
20095
20104
20114
20121
20141
20161
20175
20184
20197
20203
20213
202210
20233
20247

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status82

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ANRS, Emerging Infectious Diseases10
Guang'anmen Hospital of China Academy of Chinese Medical Sciences3
National Institute of Allergy and Infectious Diseases (NIAID)3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Gilead Sciences2
Hadassah Medical Organization2
Hospital Clinic of Barcelona2
London School of Hygiene and Tropical Medicine2
Makerere University2
National Center for Research Resources (NCRR)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections82
Acquired Immunodeficiency Syndrome16
Sexually Transmitted Diseases4
Cytomegalovirus Retinitis2
Hepatitis B2
Tuberculosis2
AIDS-Related Opportunistic Infections1
Anus Neoplasms1
Anxiety Disorders1
Cocaine-Related Disorders1

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.